Increased levels of prothrombin, apolipoprotein A-IV, and haptoglobin were found in the cerebrospinal fluid of Huntington's disease patients compared to controls. Proteomic studies on cerebrospinal fluid are important for determining if increases in these proteins are correlated with Huntington's disease development and could serve as specific biomarkers. While BBB integrity was maintained, the findings suggest the proteins are produced in the central nervous system and are not related to serum concentrations, indicating a role in the disease itself rather than passive diffusion from blood.